GSSSX
Price
$33.49
Change
+$0.05 (+0.15%)
Updated
Oct 17 closing price
Net Assets
887.06M
UBVVX
Price
$83.71
Change
+$0.45 (+0.54%)
Updated
Oct 17 closing price
Net Assets
9.51B
Interact to see
Advertisement

GSSSX vs UBVVX

Header iconGSSSX vs UBVVX Comparison
Open Charts GSSSX vs UBVVXBanner chart's image
Goldman Sachs Small Cap Value Svc
Price$33.49
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets887.06M
Undiscovered Managers Behavioral Val R5
Price$83.71
Change+$0.45 (+0.54%)
VolumeN/A
Net Assets9.51B
GSSSX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
GSSSX vs. UBVVX commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSSSX is a Buy and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.51B vs. GSSSX (887M). UBVVX pays higher dividends than GSSSX: UBVVX (1.80) vs GSSSX (0.84). GSSSX was incepted earlier than UBVVX: GSSSX (28 years) vs UBVVX (9 years). GSSSX (1.57) is less costly to investors than UBVVX (0.95). GSSSX is a more actively managed with annual turnover of: 83.00 vs. UBVVX (35.00). GSSSX (0) and UBVVX (0) have matching initial minimum investment requirements. UBVVX annual gain was more profitable for investors over the last year : -4.88 vs. GSSSX (-16.61). UBVVX return over 5 years is better than : 76.89 vs. GSSSX (-15.38).
GSSSXUBVVXGSSSX / UBVVX
Total Expense Ratio1.460.90162%
Annual Report Gross Expense Ratio1.570.95165%
Fund Existence28 years9 years-
Gain YTD5.814-0.322-1,808%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets887M9.51B9%
Annual Yield % from dividends0.841.8046%
Returns for 1 year-16.61-4.88340%
Returns for 3 years-16.9011.15-152%
Returns for 5 years-15.3876.89-20%
Returns for 10 years-30.21N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLBL8.350.27
+3.29%
Polibeli Group Ltd
NCDL13.750.21
+1.55%
Nuveen Churchill Direct Lending Corp
VRM26.110.06
+0.23%
Vroom Inc
KZIA7.000.01
+0.14%
Kazia Therapeutics Limited
TER138.16-1.14
-0.82%
Teradyne